DermaJect
DermaJect is a company specializing in micro-needle technology and innovative drug delivery systems. They focus on developing high-quality micro-needle manufacturing processes, including the DermaMT™ technology, and are engaged in creating advanced micro-needle patches for cosmetic and pharmaceutical applications. Their mission is to overcome the limitations of traditional drug delivery systems through their unique micro-needle solutions, aiming to improve patient convenience and treatment efficacy.
Industries
Nr. of Employees
small (1-50)
DermaJect
Gyeonggi-do, Uiwang-si, Imi-ro 40, Indukwon IT Valley, Bldg. B, 312
Products
Cosmeceutical dissolvable microneedle patches (consumer products)
Marketed cosmetic microneedle patch products intended for indications such as wrinkle improvement, acne treatment, and dark-spot care; produced via dissolvable microneedle manufacturing processes.
Development-stage drug-loaded microneedle patches (peptides: semaglutide, insulin, GLP-1 analogs)
R&D-stage microneedle patches designed to deliver peptide therapeutics (examples in development include semaglutide and insulin), incorporating multilayer designs and stability-focused formulations; undergoing nonclinical evaluation and stability testing.
Micro-mold based microneedle manufacturing platform (technology platform)
Platform technology for producing dissolvable microneedle patches that includes manufacturing tooling, processes, and automation methods; subject to patent protection for manufacturing device and method.
Cosmeceutical dissolvable microneedle patches (consumer products)
Marketed cosmetic microneedle patch products intended for indications such as wrinkle improvement, acne treatment, and dark-spot care; produced via dissolvable microneedle manufacturing processes.
Development-stage drug-loaded microneedle patches (peptides: semaglutide, insulin, GLP-1 analogs)
R&D-stage microneedle patches designed to deliver peptide therapeutics (examples in development include semaglutide and insulin), incorporating multilayer designs and stability-focused formulations; undergoing nonclinical evaluation and stability testing.
Micro-mold based microneedle manufacturing platform (technology platform)
Platform technology for producing dissolvable microneedle patches that includes manufacturing tooling, processes, and automation methods; subject to patent protection for manufacturing device and method.
Services
Design and manufacture of dissolvable microneedle patches for cosmetic and pharmaceutical customers through partnership agreements and global ODM services.
Collaborative development of microneedle formulations and device architectures for delivery of peptides and other actives, including multilayer designs and room-temperature-stable formulations.
Analytical testing services applying liquid chromatography and immunoassays to verify content and structural stability of actives in microneedle formulations during storage and development.
Development and application of automated manufacturing equipment and methods to improve throughput and reduce operator skill dependence in microneedle patch production.
Design and manufacture of dissolvable microneedle patches for cosmetic and pharmaceutical customers through partnership agreements and global ODM services.
Collaborative development of microneedle formulations and device architectures for delivery of peptides and other actives, including multilayer designs and room-temperature-stable formulations.
Analytical testing services applying liquid chromatography and immunoassays to verify content and structural stability of actives in microneedle formulations during storage and development.
Development and application of automated manufacturing equipment and methods to improve throughput and reduce operator skill dependence in microneedle patch production.
Expertise Areas
- Microneedle patch manufacturing
- Transdermal peptide delivery
- Peptide formulation stabilization
- Multilayer microneedle design
Key Technologies
- Dissolvable microneedles
- Micro-mold fabrication
- Multi-layer microneedle architecture
- Automated demolding and adhesive integration equipment
News & Updates
DermaJect, a micro-needle specialist company, has launched a new product, the 'Arpe Smile Care Solution Eleven Patch,' which is a wrinkle improvement patch embedded with the new ingredient iN-SIS5, a neurotoxin alternative. The product is an upgraded version of a previous product, with enhanced quality and packaging, and is available on various online platforms.
DermaJect is advancing the development of a micro-needle patch that contains Semaglutide, a GLP-1 analog, to address issues related to injectable obesity treatments. The company aims to improve patient compliance and stability of the drug during storage, leveraging their proprietary micro-needle manufacturing technology 'DermaMT BIO®'.
DermaJect has obtained a patent for a device and method that simplifies the manufacturing process of micro-needle patches, enabling automation and increased production efficiency.
DermaJect, a micro-needle specialist company, has launched a new product, the 'Arpe Smile Care Solution Eleven Patch,' which is a wrinkle improvement patch embedded with the new ingredient iN-SIS5, a neurotoxin alternative. The product is an upgraded version of a previous product, with enhanced quality and packaging, and is available on various online platforms.
DermaJect is advancing the development of a micro-needle patch that contains Semaglutide, a GLP-1 analog, to address issues related to injectable obesity treatments. The company aims to improve patient compliance and stability of the drug during storage, leveraging their proprietary micro-needle manufacturing technology 'DermaMT BIO®'.
DermaJect has obtained a patent for a device and method that simplifies the manufacturing process of micro-needle patches, enabling automation and increased production efficiency.